Graticule Asia Macro Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-150,000
Closed -$25.1M 142
2019
Q2
$25.1M Buy
+150,000
New +$20.8M 1.35% 20
2016
Q2
Sell
-14,557
Closed -$3.9M 103
2016
Q1
$3.9M Sell
14,557
-64,891
-82% -$18.6M 0.31% 59
2015
Q4
$24.8M Buy
79,448
+69,948
+736% +$20.8M 4.05% 2
2015
Q3
$2.58M Sell
9,500
-47,546
-83% -$14.6M 0.3% 47
2015
Q2
$17.3M Buy
+57,046
New +$17M 0.83% 20

Other funds holding AGN

Graticule Asia Macro Advisors's AGN Position: Q3 2019 in Review

Graticule Asia Macro Advisors sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 150,000 shares — an estimated $25.1M sold.

Graticule Asia Macro Advisors first reported a position in AGN in Q2 2015 and held it in 5 quarters. The position peaked at $25.1M in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Graticule Asia Macro Advisors reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 150,000 Allergan plc shares in Q3 2019, an estimated $25.1M.
  • Graticule Asia Macro Advisors first reported a position in Allergan plc in Q2 2015 and held it in 5 quarters.
  • Graticule Asia Macro Advisors's Allergan plc position peaked at $25.1M in Q2 2019.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Graticule Asia Macro Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.